WASHINGTON (CN) – Because of the threats of abuse and trafficking of the pain killer carisoprodol, sold as “Soma,” the Drug Enforcement Administration plans to place controls on its movement, according to a proposed regulation.
Currently, the drug needs a regular prescription, but, since carisoprodol is being diverted and may be addictive, according to a report by the Food and Drug Administration, the DEA plans to make it a Schedule IV controlled substance.
Processing or moving a substance classified into Schedule IV under the Controlled Substances Act requires registration with the DEA. The drug also must have security and special labeling. It would be a crime to handle carisoprodol and products containing it, without following the controls.
Click the document icon for this and other regulations.